Quantifying HLA Mismatches at Epitope Level in Haplo‐ HSCT : Impact in the Outcome in Strategies Using PTCy
HLA · 2024
DOI: 10.1111/tan.15738 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2024. Verfasst von Francisco Javier Gil-Etayo und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, University Hospital of Salamanca, Salamanca, Spain. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Graft vs Host Disease, HLA Antigens, Epitopes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Haploidentical haematopoietic stem cell transplantation (haplo‐HSCT) is one of the most effective therapies for treating malignant haematological disorders. However, HLA disparities are significant barriers to the success of this process since they increase the risk of graft versus host disease (GvHD). HLA disparities quantification could help to anticipate the probability and degree of GvHD, but the best tool for such quantification remains a challenge. The aim of this study was to quantify the degree of HLA epitope incompatibilities using PIRCHE (Predicted Indirectly Recognisable HLA Epitopes) algorithm for immunogenicity prediction and their potential relationship with GvHD degree and clinical outcome. We studied 145 patients who underwent a haplo‐HSCT with post‐transplant cyclophosphamide (PTCy) from a related donor between 2013 and 2020 at our centre evaluating molecular HLA mismatches by PIRCHE‐algorithm. Patients with PIRCHE Score (PS) I + II > 38 in GvH direction, developed acute GvHD grade II–IV earlier than their counterparts (HR: 1.71, 95% CI: 1.02–2.87, p = 0.032). In addition, PS‐B > 1 in GvH direction was an independent risk factor for chronic GvHD, (HR: 2.51, 95% CI 1.17–5.36, p = 0.017). A higher incidence of relapse was found for patients with PS‐II > 28 HvG (HR: 9.16, 95% CI: 2.47–33.92, p < 0.001) which also favoured a worse GvHD/relapse‐free survival in patients with PS‐II > 27 in HvG direction (HR: 1.88, 95% CI: 1.11–3.18, p = 0.017). These findings indicate that the alloreactivity inferred by epitope HLA disparities is associated with post‐transplant outcomes. Thus, analysing PS could benefit the selection of the most suitable donors allowing patient stratification based on HLA mismatches in the context of haplo‐HSCT with PTCy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.
- Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.
- Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
- Centro de Investigación Contra el Cáncer (CIC), Salamanca, Spain.
- Transfusion Centre of Comunidad Valenciana, Valencia, Spain.
- Immunology Unit, Clinical Analysis Department, Albacete University Hospital Complex, Albacete, Spain.
ORCID-Profile: Francisco Javier Gil-Etayo, Jairo Eduardo Niño-Ramírez, Daniel Arroyo-Sánchez, Ariadna Vicente Parra, Isabel Jiménez Hernaz, Pilar Terradillos Sánchez, Francisco Boix, Miguel Alcoceba, Fermín Sánchez-Guijo, Ramón García-Sanz, Lucía López-Corral, Amalia Tejeda Velarde
Zitieren
APA
Gil-Etayo, F. J., Niño-Ramírez, J. E., Fonseca-Santos, M., Arroyo-Sánchez, D., Navarro-Bailón, A., Vicente Parra, A., Jiménez Hernaz, I., Terradillos Sánchez, P., Boix, F., Alcoceba, M., Marín, L., Pérez-López, E., Cabrero, M., Martín-López, A. Á., López, M., Baile, M., Avendaño, A., Cabero, A., García-Bacelar, A., …, & Tejeda Velarde, A. (2024). Quantifying HLA Mismatches at Epitope Level in Haplo‐ HSCT : Impact in the Outcome in Strategies Using PTCy. HLA. https://doi.org/10.1111/tan.15738
Vancouver
Gil-Etayo FJ, Niño-Ramírez JE, Fonseca-Santos M, Arroyo-Sánchez D, Navarro-Bailón A, Vicente Parra A, et al. Quantifying HLA Mismatches at Epitope Level in Haplo‐ HSCT : Impact in the Outcome in Strategies Using PTCy. HLA. 2024. doi:10.1111/tan.15738
BibTeX
@article{GilEtayo2024,
author = {Gil-Etayo, Francisco Javier and Niño-Ramírez, Jairo Eduardo and Fonseca-Santos, Marta and Arroyo-Sánchez, Daniel and Navarro-Bailón, Almudena and Vicente Parra, Ariadna and Jiménez Hernaz, Isabel and Terradillos Sánchez, Pilar and Boix, Francisco and Alcoceba, Miguel and Marín, Luis and Pérez-López, Estefanía and Cabrero, Mónica and Martín-López, Ana África and López, Miriam and Baile, Mónica and Avendaño, Alejandro and Cabero, Almudena and García-Bacelar, Ana and Vázquez, Lourdes and Sánchez-Guijo, Fermín and García-Sanz, Ramón and López-Corral, Lucía and Tejeda Velarde, Amalia},
title = {Quantifying HLA Mismatches at Epitope Level in Haplo‐ HSCT : Impact in the Outcome in Strategies Using PTCy},
journal = {HLA},
year = {2024},
doi = {10.1111/tan.15738}
}
EUVIMED